People · Operator
Named in public records as an officer, director or promoter · active 2011–2020 · Pharmaceuticals, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Orphion Therapeutics, Inc. | — | Pharmaceuticals | Series A | $5.3M | $140.5M | 2020 |
| SKS Ocular 1, LLC | — | Other Health Care | Pre-Seed | $150K | $4.6M | 2011 |
Jason Slakter at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Jason Slakter on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Michael Mashaal | 1 | 3 |
| Jeanmarie Guenot | 1 | 2 |
| Glenn Stoller | 1 | 1 |
| Nickolay Voronin | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.